Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,767 | 15,944 | 20,435 | 771 | N/A |
| Receivables | 12 | 64 | 86 | N/A | N/A |
| TOTAL | $11,915 | $16,532 | $20,588 | $772 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 96 | 128 | 20 | 4 | N/A |
| Other Non-Current Assets | 21 | 20 | 12 | 14 | 0 |
| TOTAL | $118 | $148 | $32 | $18 | $N/A |
| Total Assets | $12,033 | $16,680 | $20,620 | $790 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 333 | 220 | 448 | 68 | 0 |
| Accrued Expenses | 1,097 | 83 | 325 | 275 | N/A |
| TOTAL | $1,430 | $303 | $773 | $343 | $N/A |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 43 | 54 | 0 | 0 | 0 |
| TOTAL | $43 | $54 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,473 | $357 | $773 | $343 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,165 | 12,564 | 12,528 | N/A | N/A |
| Common Shares | 14 | 13 | 13 | 69 | N/A |
| Retained earnings | -20,463 | -9,899 | -5,759 | -3,030 | N/A |
| TOTAL | $10,560 | $16,323 | $19,847 | $447 | $N/A |
| Total Liabilities And Equity | $12,033 | $16,680 | $20,619 | $790 | $0 |